Feb 10 (Reuters)-
Medrx.Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2020 Dec 31, 2019 Dec 31, 2021 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 115 mln 169 mln 327 mln 7 mln
(-32.2 pct) (+1922.9 pct) (+184.2 pct) (-53.0 pct)
Operating loss 1.13 loss 1.63 loss 886 mln loss 814 mln
Recurring loss 1.15 loss 1.63 loss 890 mln loss 817 mln
Net
Net loss 1.11 loss 1.62 loss 892 mln loss 819 mln
EPS loss 68.61 yen loss 134.32 yen loss 45.93 yen loss 42.15 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Medrx.Co., Ltd..
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T